Estee Lauder Companies (The)
 
 
 
 
公司概覽
業務類別 Household & Personal Products
業務概覽 Since its founding in 1946, Estee Lauder has become a leading global manufacturer and marketer of prestige skincare (nearly half of sales), makeup (28%), fragrance (19%), and haircare products (4%). Beyond its namesake brand, the firm's portfolio of offerings includes Clinique, M.A.C., La Mer, Jo Malone London, and Tom Ford, among others. The US and China each account for about one-quarter of its consolidated sales. The firm sells its products through physical and e-commerceplatforms at company-owned outlets alongside department stores, specialty retailers, and salons globally.
公司地址 767 Fifth Avenue, New York, NY, USA, 10153
電話號碼 +1 212 572-4200
傳真號碼 +1 212 277-2355
公司網頁 https://www.elcompanies.com
員工數量 55000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Rashida La Lande Executive Vice President and General Counsel 美元 927.00K 19/08/2026
Ms. Jane Hertzmark Hudis Executive Vice President and Chief Brand Officer 美元 1.34M 19/08/2026
Mr. Roberto Canevari Executive Vice President and Chief Value Chain Officer 美元 1.13M 19/08/2026
Ms. Meridith Webster Executive Vice President and Chief Communications and Public Affairs Officer -- 19/08/2026
Mr. Stephane de la Faverie President, Chief Executive Officer and Director 美元 1.50M 30/09/2026
Mr. Akhil Shrivastava Executive Vice President, Chief Financial Officer and Principal Accounting Officer 美元 900.00K 19/08/2026
Mr. Michael Bowes Executive Vice President and Chief People Officer -- 19/08/2026
Mr. Rene Lammers Executive Vice President and Chief Research and Innovation Officer -- 19/08/2026
 
董事會成員
董事會 職務 更新日期
Ambassador Charlene Barshefsky Independent Director 30/09/2026
Mr. Matthew E. Rubel Independent Director 30/09/2026
Mr. Richard F. Zannino Lead Independent Director 30/09/2026
Mr. Ronald S. Lauder Chairman, Clinique Laboratories, LLC 19/08/2026
Mr. William P. Lauder Chairman of the Board 30/09/2026
Mr. Barry S. Sternlicht Independent Director 30/09/2026
Mr. Paul J. Fribourg Independent Director 30/09/2026
Ms. Jane Lauder Director 30/09/2026
Mr. Eric L. Zinterhofer Director 30/09/2026
Ms. Annabelle Yu Long Independent Director 30/09/2026
Ms. Jennifer G. Tejada Independent Director 30/09/2026
Mr. Gary M. Lauder Director 30/09/2026
Ms. Jennifer Y. Hyman Independent Director 24/07/2026
Ms. Dana Strong Independent Director 30/09/2026
Mr. Arturo Nunez Independent Director 30/09/2026
Mr. Stephane de la Faverie President, Chief Executive Officer and Director 30/09/2026
Mr. Jean-Frederic Dufour Independent Director 30/09/2026
 
所屬ETF (更新日期: 24/10/2026 02:14)
代號 名稱 佔比% ▼ 持有日期
STXGStrive 1000 Growth ETF0.0001%30/09/2026
XYLGGlobal X S&P 500® Covered Call & Gr ETF0.0001%30/09/2026
EGUSiShares ESG Aware MSCI USA Growth ETF0.0001%30/09/2026
FEACFidelity Enhanced U.S. All-Cap Eq ETF0.0001%30/09/2026
GLOFiShares Global Equity Factor ETF0.0001%30/09/2026
MNZLManzil Russell Halal USA Broad MarketETF0.0001%30/09/2026
PEPSParametric Equity Plus ETF0.0001%30/09/2026
URSPProShares Ultra S&P 500 Equal Weight0.0001%31/05/2026
XRMIGlobal X S&P 500® Risk Managed Inc ETF0.0001%30/09/2026
NTSDWisdomTree Efficient U.S. Pls Intl Eq Fd0.0001%30/09/2026
TMIDT. Rowe Price Mid-Cap Equity ResearchETF0.0001%30/09/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.0001%30/09/2026
RAUSRACWI US ETF0.0001%30/09/2026
PHDGInvesco S&P 500® Downside Hedged ETF0.0001%30/09/2026
QARPXtrackers Russell 1000 US QARP ETF0.0001%30/09/2026
HAWGHCM Hedged Equity ETF0.0001%30/09/2026
OWNInside Ownership 100 ETF0.00005%30/09/2026
GOFGuggenheim Strategic Opp Fund0.00005%28/02/2026
SPXVProShares S&P 500® ex-Health Care0.00005%30/09/2026
SPXDXtrackers S&P 500 Divers Sect Weight ETF0.00004%30/09/2026
  1    2    3    4    5    6    7    8    9    10    11   12    13    14    15    16    17  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.